Exemestane 25 MG Clinical Trials
3 recruitingDrug
Phase 31Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 3
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
HER2-negative Breast CancerER Positive Breast CancerStage III Breast Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC220 enrolled109 locationsNCT05512364
Recruiting
Phase 1
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Breast Cancer MetastaticNeuroendocrine TumorsRenal Cell Carcinoma (RCC)+2 more
SAPU NANO (US) LLC27 enrolled1 locationNCT07369505
Recruiting
Phase 2
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
Breast Cancer
Andrea DeCensi140 enrolled1 locationNCT06364267